Assembly Biosciences EPS
The Earnings per Share (EPS) of Assembly Biosciences (ASMB) as of Oct 12, 2026 is -0.55 USD. In the previous year, Earnings per Share (EPS) was -6.10 USD — a change of -91.06% (higher).
Get this data via API
Financial Data API
EPS
-0.55USD
YoY
-91.06%
Last updated:
The Assembly Biosciences EPS history
3 Years
10 Years
25 Years
Max
| YEAR | EPS | YoY |
|---|---|---|
| est | -1.52USD | -50.86% |
| est | -3.09USD | +58.42% |
| est | -1.95USD | -35.96% |
| est | -3.05USD | +401.32% |
| est | -0.61USD | +11.38% |
| -0.55USD | -91.06% | |
| -6.10USD | -45.33% | |
| -11.17USD | -50.68% | |
| -22.64USD | -20.54% | |
| -28.50USD | +81.93% | |
| -15.66USD | -43.72% | |
| -27.83USD | -21.28% | |
| -35.35USD | +67.09% | |
| -21.16USD | -17.45% | |
| -25.63USD | +55.18% | |
| -16.52USD | -22.39% | |
| -21.28USD | -51.53% | |
| -43.91USD | -39.58% | |
| -72.68USD | -47.48% | |
| -138.38USD | +1,193.65% | |
| -10.70USD | -78.91% | |
| -50.72USD | -51.31% | |
| -104.17USD | — |
Assembly Biosciences Stock analysis
Frequently Asked Questions about Assembly Biosciences stock
Earnings per Share (EPS) of Assembly Biosciences is -0.55 USD in 2025.
Earnings per Share (EPS) of Assembly Biosciences changed from -6.10 USD to -0.55 USD, representing a -91.06% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Assembly Biosciences since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Income Statement — Assembly Biosciences
All Key Metrics — Assembly Biosciences
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth